Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Colm J. O’Rourke, Massimiliano Salati, Colin Rae, et al.
Gut (2023), pp. gutjnl-330748
Open Access | Times Cited: 12

Showing 12 citing articles:

Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
Minae An, Arnav Mehta, Byung‐Hoon Min, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 766-785
Open Access | Times Cited: 17
Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery
Junxian Cao, Caifeng Li, Zhao Cui, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2946-2968
Open Access | Times Cited: 16
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101171-101171
Open Access | Times Cited: 1
Strategies to enhance the response of liver cancer to pharmacological treatments
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 1
Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects
Jiayi Wang, Siyan Liu, Yi Cao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Emerging Roles of Spatial Transcriptomics in Liver Research
Naoto Fujiwara, Genki Kimura, Hayato Nakagawa
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 115-132
Closed Access
Cholangiokarzinom: Transkriptomprofile prognostizieren Chemotherapieerfolg

Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 09, pp. 1358-1359
Closed Access
Application of preoperative NLR-based prognostic model in predicting prognosis of intrahepatic cholangiocarcinoma following radical surgery
Shuo Qi, Zhongzhi Ma, Lian Shen, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Cholangiokarzinom: Transkriptomprofile prognostizieren Chemotherapieerfolg

TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 09, pp. 570-570
Closed Access
Multimodal single-cell profiling reveals cancer crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients
Lara R. Heij, Sikander Hayat, Konrad Reichel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Targeted therapies in biliary tract cancer—when precision becomes imprecise
Colm J. O’Rourke, Jakob Vasehus Schou, Jesper B. Andersen, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100085-100085
Open Access
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma
María Arechederra, Andrea Casadei Gardini, Chiara Raggi
Gut (2023), pp. gutjnl-331119
Closed Access | Times Cited: 1
Page 1

Scroll to top